2,200 Shares in Humana Inc. $HUM Purchased by Sumitomo Mitsui Financial Group Inc.

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Sumitomo Mitsui Financial Group Inc. acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 2,200 shares of the insurance provider's stock, valued at approximately $582,000.

Several other hedge funds and other institutional investors have also modified their holdings of HUM. Revolve Wealth Partners LLC purchased a new stake in shares of Humana during the fourth quarter worth $202,000. Mariner LLC raised its holdings in shares of Humana by 4.0% during the fourth quarter. Mariner LLC now owns 13,461 shares of the insurance provider's stock worth $3,415,000 after acquiring an additional 517 shares in the last quarter. Forum Financial Management LP increased its position in Humana by 62.0% during the fourth quarter. Forum Financial Management LP now owns 1,916 shares of the insurance provider's stock worth $486,000 after buying an additional 733 shares during the last quarter. First Trust Advisors LP increased its position in Humana by 78.6% during the fourth quarter. First Trust Advisors LP now owns 93,328 shares of the insurance provider's stock worth $23,678,000 after buying an additional 41,070 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Humana by 1.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,059,737 shares of the insurance provider's stock worth $268,877,000 after buying an additional 19,091 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have commented on HUM shares. Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price on the stock in a research report on Thursday, May 1st. Truist Financial lowered their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Barclays set a $275.00 target price on shares of Humana and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. Robert W. Baird lowered their target price on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Finally, Piper Sandler lowered their target price on shares of Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research report on Thursday, July 31st. Seven research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to data from MarketBeat.com, Humana has a consensus rating of "Hold" and an average price target of $283.29.

Humana Stock Performance

Shares of Humana stock traded up $4.2280 during trading on Thursday, reaching $294.2280. The company's stock had a trading volume of 1,471,312 shares, compared to its average volume of 1,866,874. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The business's fifty day moving average price is $247.28 and its 200-day moving average price is $253.70. The firm has a market cap of $35.39 billion, a price-to-earnings ratio of 22.58, a price-to-earnings-growth ratio of 1.71 and a beta of 0.44. Humana Inc. has a one year low of $206.87 and a one year high of $382.72.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. Humana's dividend payout ratio (DPR) is presently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.